Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (611-620 of 895) with videos related to

Pageof 90
Sort By:
Pediatric Nephrology (Berlin, Germany)|November 26, 2015
Liver transplantation for aHUS: still needed in the eculizumab era?Rosanna Coppo, Roberto Bonaudo, R Licia Peruzzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2013
In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody developmentMarta Todeschini, Monica Cortinovis, Norberto Perico, et al.
The New England Journal of Medicine|January 27, 2006
Long-term outcome of renal transplantation from older donorsGiuseppe Remuzzi, Paolo Cravedi, Annalisa Perna, et al.
Thrombosis and Haemostasis|March 1, 2005
Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathiesMaria Piedad Ruiz-Torres, Federica Casiraghi, Miriam Galbusera, et al.
JNMA; Journal of the Nepal Medical Association|April 18, 2013
Community-based screening for chronic kidney disease, hypertension and diabetes in DharanSanjib Kumar Sharma, Subodh Dhakal, Lekhjung Thapa, et al.
Nephron|March 20, 2019
Hemolytic Uremic Syndrome in an Infant with Primary Hyperoxaluria Type II: An Unreported Clinical AssociationElisabetta Valoti, Marta Alberti, Camillo Carrara, et al.
Nephron. Clinical Practice|April 24, 2010
Prevention and transplantation in chronic kidney disease: what is achievable in emerging countries? Meeting report: Bamako meeting December 4-6, 2008Veerle P Persy, Giuseppe Remuzzi, Norberto Perico, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 15, 2021
Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practiceNine Knoers, Corinne Antignac, Carsten Bergmann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 16, 2011
PPARγ2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studiesSalvatore De Cosmo, Sabrina Prudente, Olga Lamacchia, et al.
Molecular Immunology|August 3, 2006
Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndromeAnna Richards, M Kathryn Liszewski, David Kavanagh, et al.
Pageof 90

Showing results (611-620 of 895) with videos related to

Sort By:
Pageof 90
Pediatric Nephrology (Berlin, Germany)|November 26, 2015
Liver transplantation for aHUS: still needed in the eculizumab era?Rosanna Coppo, Roberto Bonaudo, R Licia Peruzzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2013
In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody developmentMarta Todeschini, Monica Cortinovis, Norberto Perico, et al.
The New England Journal of Medicine|January 27, 2006
Long-term outcome of renal transplantation from older donorsGiuseppe Remuzzi, Paolo Cravedi, Annalisa Perna, et al.
Thrombosis and Haemostasis|March 1, 2005
Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathiesMaria Piedad Ruiz-Torres, Federica Casiraghi, Miriam Galbusera, et al.
JNMA; Journal of the Nepal Medical Association|April 18, 2013
Community-based screening for chronic kidney disease, hypertension and diabetes in DharanSanjib Kumar Sharma, Subodh Dhakal, Lekhjung Thapa, et al.
Nephron|March 20, 2019
Hemolytic Uremic Syndrome in an Infant with Primary Hyperoxaluria Type II: An Unreported Clinical AssociationElisabetta Valoti, Marta Alberti, Camillo Carrara, et al.
Nephron. Clinical Practice|April 24, 2010
Prevention and transplantation in chronic kidney disease: what is achievable in emerging countries? Meeting report: Bamako meeting December 4-6, 2008Veerle P Persy, Giuseppe Remuzzi, Norberto Perico, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 15, 2021
Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practiceNine Knoers, Corinne Antignac, Carsten Bergmann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 16, 2011
PPARγ2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studiesSalvatore De Cosmo, Sabrina Prudente, Olga Lamacchia, et al.
Molecular Immunology|August 3, 2006
Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndromeAnna Richards, M Kathryn Liszewski, David Kavanagh, et al.
Pageof 90